Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsector
Small molecules
Indications
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 17
Description
Enveda is a clinical-stage biotechnology company developing novel small molecule therapeutics discovered from nature using an AI-enabled drug discovery platform. The company's product ENV-294 is a first-in-class, once-daily oral small molecule with a Dupi-like efficacy and safety profile, with pan-endotype potential in atopic dermatitis and other inflammatory conditions. The company's another product ENV-308 is a first-in-class, daily oral small molecule that sustains long-term metabolic health,...
